News
Stay up to date with MEGIN’s latest news, including customer announcements, press releases, and the MEGIN Matters newsletter.
Subscribe to MEGIN Matters
Don’t miss the latest MEG insights and MEGIN news – complete the form below to be added to our mailing list and receive MEGIN Matters right in your inbox!
Explore news
MEGIN Matters – September 2023
We’re excited to be attending the 16th Annual ASFNR Meeting in Boston on October 7-9, 2023. We also look forward to sponsoring the MEG-UKI Conference at Trinity College Dublin,...
MEGIN Matters – July 2023
We’re delighted to be sponsoring the 1st MEG Symposium at the Carl von Ossietzky University of Oldenburg. The aim is to share the latest developments in MEG research and includes...
Hiroshima University announces the sale of the first TRIUX™ neo in Japan
Hiroshima University Hospital press release – an announcement from our customer-partner Hiroshima University Hospital established its Epilepsy Center in January 2014. The...
Fixel Institute expands care with new neuroimaging and clinical research suites
A 15,000-square-foot neuroimaging suite that includes four high-tech imaging machines — including one of just three in the Southeast — opened Monday as the Norman Fixel Institute...
MEGIN’s latest global customer survey finds customers are extremely satisfied with the customer service, project management and installation offered by MEGIN
Earlier this year, as part of its commitment to continually improving its customer service, MEGIN partnered with B2B international – a full-service market research company, to...
Bridging the gap: Adopting innovative technology in UK clinical settings
The role of Magnetoencephalography (MEG) technology, its clinical use in the UK, and a vision for the future. Stefano Seri, emeritus professor of clinical neurophysiology at the...
Advanced Imaging in Epilepsy: How MEG Can Assist in Surgery
In this webinar, viewers will learn how MEG is a key part of the epilepsy surgery evaluation, including information about the basics and safety of a MEG study, and hear about how...
MEGIN joins over 30 UK HealthTech pioneers on ABHI mission to bolster trade ties in California
MEGIN is delighted to be among the delegates of leading UK innovators heading to California this week (12-16 September 2022) as part of ABHI’s mission to bolster trade...
MEGIN joins over 20 UK HealthTech innovators on ABHI mission to strengthen trade partnerships in Tennessee
This month, MEGIN is delighted to be among the delegate of leading UK HealthTech innovators heading to Tennessee to strengthen trade links and showcase their products and...
MEGIN joins 28 UK HealthTech pioneers on ABHI mission to strengthen trade relations in Texas
MEGIN is excited to be among the delegate of pioneering HealthTech companies heading to Texas as part of the first major US trade mission organized by the Association of British...
MEGIN announces sale of TRIUX™ neo to University of Nebraska Medical Center
HELSINKI, FINLAND (March 07, 2022) - MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, by the...
Geneva at the heart of the human brain
It’s a first in Switzerland: the Human Neuroscience Platform (HNP) now hosts a magnetoencephalography (MEG) facility with the purchase of a MEGIN TRIUX™ neo, a state-of-the-art...
MEGIN announces sale of TRIUX™ neo to the Norman Fixel Institute for Neurological Diseases at UF Health
MEGIN is pleased to announce the sale of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, to the Norman Fixel Institute for Neurological Diseases at...
MEGIN Joins ABHI UK Pavilion Showcasing Strengths of UK HealthTech at Arab Health 2022
MEGIN is delighted to be joining the Association of British HealthTech Industries (ABHI) UK Pavilion at Arab Health 2022, which is taking place from 24- 27 January in Dubai. The...
How Magnetoencephalography is Optimising Neurosurgery – By: Professor Stefano Seri MD, FRCP
Despite its success in pre-surgical evaluation in localising brain activity, as well as being approved for the pre-surgical evaluation of medically refractory epilepsy,...